Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio (2016 - 2025)
Rocket Pharmaceuticals (RCKT) has disclosed Interest Coverage Ratio for 9 consecutive years, with 92.95 as the latest value for Q4 2025.
- Quarterly Interest Coverage Ratio rose 29.88% to 92.95 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 122.55 through Dec 2025, up 15.4% year-over-year, with the annual reading at 122.55 for FY2025, 15.4% up from the prior year.
- Interest Coverage Ratio hit 92.95 in Q4 2025 for Rocket Pharmaceuticals, up from 110.46 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 22.68 in Q1 2021 to a low of 156.5 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 122.64 across 5 years, with a median of 133.76 in 2023.
- Biggest five-year swings in Interest Coverage Ratio: plummeted 928.35% in 2021 and later grew 29.88% in 2025.
- Year by year, Interest Coverage Ratio stood at 95.75 in 2021, then plummeted by 54.49% to 147.93 in 2022, then increased by 8.98% to 134.64 in 2023, then rose by 1.55% to 132.55 in 2024, then increased by 29.88% to 92.95 in 2025.
- Business Quant data shows Interest Coverage Ratio for RCKT at 92.95 in Q4 2025, 110.46 in Q3 2025, and 150.42 in Q2 2025.